What is the current valuation of the softgel capsule market in China as of 2024?

The softgel capsule market in China was valued at $415.72 Million in 2024. Read More

What is the projected market valuation for the softgel capsule market in China by 2035?

The projected valuation for the softgel capsule market in China is $753.54 Million by 2035. Read More

What is the expected CAGR for the softgel capsule market in China during the forecast period 2025 - 2035?

The expected CAGR for the softgel capsule market in China during the forecast period 2025 - 2035 is 5.56%. Read More

Which application segment had the highest valuation in 2024 for the softgel capsule market in China?

In 2024, the Pharmaceuticals segment had the highest valuation at $124.74 Million. Read More

What are the projected valuations for the nutraceuticals segment in the softgel capsule market by 2035?

The nutraceuticals segment is projected to reach $150.0 Million by 2035. Read More

Which ingredient segment is expected to show significant growth in the softgel capsule market by 2035?

The Gelatin ingredient segment is expected to grow significantly, reaching $280.0 Million by 2035. Read More

What distribution channel is anticipated to have the highest valuation in the softgel capsule market by 2035?

The Pharmacies distribution channel is anticipated to have the highest valuation at $220.0 Million by 2035. Read More

Who are the key players in the softgel capsule market in China?

Key players in the softgel capsule market include Catalent, Amway, BASF, Lonza, FMC Corporation, Aenova Group, Soft Gel Technologies, and Natural Alternatives International. Read More

What formulation type is projected to dominate the softgel capsule market in China by 2035?

The Gelled formulation type is projected to dominate the market, reaching $343.96 Million by 2035. Read More

How does the growth of the dietary supplements segment compare to other segments in the softgel capsule market?

The dietary supplements segment is projected to grow to $158.54 Million by 2035, indicating robust growth compared to other segments. Read More

China Softgel Capsule Market

China Softgel Capsule Market Research Report By Type (Gelatin Type, Non-Animal Type) and By Application (Vitamins, Supplement, Nutrition) -Forecast to 2035

Forecast Period

2025 - 2035

CAGR

5.56%

2024 Market Size

$ 415.72 Million

2035 Market Size

$ 753.54 Million

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/47932-HCR | Pages: 200 | Author: Vikita Thakur, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Nutraceuticals
  2. 4.1.2 Pharmaceuticals
  3. 4.1.3 Cosmetics
  4. 4.1.4 Vitamins
  5. 4.1.5 Dietary Supplements
2. 4.2 Pharmaceutical, BY Ingredients (USD Million)
  1. 4.2.1 Gelatin
  2. 4.2.2 Fish Gelatin
  3. 4.2.3 Vegetable Gelatin
  4. 4.2.4 Active Ingredients
  5. 4.2.5 Colorants
3. 4.3 Pharmaceutical, BY Formulation (USD Million)
  1. 4.3.1 Single Phase
  2. 4.3.2 Multi-Phase
  3. 4.3.3 Emulsified
  4. 4.3.4 Suspended
  5. 4.3.5 Gelled
4. 4.4 Pharmaceutical, BY Distribution Channel (USD Million)
  1. 4.4.1 Online Retail
  2. 4.4.2 Pharmacies
  3. 4.4.3 Health Stores
  4. 4.4.4 Supermarkets
  5. 4.4.5 Direct Sales
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Catalent (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Amway (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 BASF (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Lonza (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 FMC Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Aenova Group (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Soft Gel Technologies (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Natural Alternatives International (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY APPLICATION
3. 6.3 CHINA MARKET ANALYSIS BY INGREDIENTS
4. 6.4 CHINA MARKET ANALYSIS BY FORMULATION
5. 6.5 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY INGREDIENTS, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY INGREDIENTS, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY FORMULATION, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY FORMULATION, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY INGREDIENTS, 2025-2035 (USD Million)
  3. 7.2.3 BY FORMULATION, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China China Softgel Capsule Market Segmentation

China Softgel Capsule Market By Application (USD Million, 2025-2035)

Nutraceuticals
China Softgel Capsule Markets
Cosmetics
Vitamins
Dietary Supplements

China Softgel Capsule Market By Ingredients (USD Million, 2025-2035)

Gelatin
Fish Gelatin
Vegetable Gelatin
Active Ingredients
Colorants

China Softgel Capsule Market By Formulation (USD Million, 2025-2035)

Single Phase
Multi-Phase
Emulsified
Suspended
Gelled

China Softgel Capsule Market By Distribution Channel (USD Million, 2025-2035)

Online Retail
Pharmacies
Health Stores
Supermarkets
Direct Sales

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”